Abstract | BACKGROUND: METHODS:
IL-8 expression in tumour tissue sections was analysed by immunohistochemistry. IL-8 expression and release in cancer cells was quantified using enzyme-linked immunosorbent assay (ELISA). Apoptosis was quantified using caspase activity and Annexin-V/PI staining. RESULTS: We observed IL-8 release from cancer cells in response to histone deacetylase inhibitor, apicidin (Api), and non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase, thapsigargin (TG). IL-8 release was increased upon TG-treatment. TG-induced IL-8 expression was reduced in the presence of Api in Bax-dependent manner. Increased apoptosis was associated with decreased IL-8 expression in response to combined treatment of TG and Api. TG and Api combination induced caspase-8 and caspase-9 dependent apoptosis. Hsp60 knockdown abrogated IL-8 expression induced by Api, TG, and their combination. The level of TGF-β, an upstream regulator of IL-8, was decreased upon Hsp60-silencing. Knocking down Hsp60 decreased IL-8 expression and its release in prostate cancer cell xenograft tumours in SCID mice. CONCLUSION: This study describes the underlying mechanism associated with apoptosis resistance mediated via Hsp60-IL-8 axis in cancer.
|
Authors | Sandeep Kumar, Jordan O'Malley, Ajay Kumar Chaudhary, Joseph R Inigo, Neelu Yadav, Rahul Kumar, Dhyan Chandra |
Journal | British journal of cancer
(Br J Cancer)
Vol. 121
Issue 11
Pg. 934-943
(11 2019)
ISSN: 1532-1827 [Electronic] England |
PMID | 31673102
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CXCL8 protein, human
- Chaperonin 60
- HSPD1 protein, human
- Interleukin-8
- Mitochondrial Proteins
- Peptides, Cyclic
- apicidin
- Thapsigargin
- CASP8 protein, human
- CASP9 protein, human
- Caspase 8
- Caspase 9
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Caspase 8
(genetics)
- Caspase 9
(genetics)
- Chaperonin 60
(genetics, metabolism)
- Gene Knockdown Techniques
- HCT116 Cells
- Heterografts
- Humans
- Interleukin-8
(genetics, metabolism)
- Male
- Mice
- Mice, SCID
- Mitochondrial Proteins
(genetics, metabolism)
- Neoplasms
(metabolism, pathology)
- PC-3 Cells
- Peptides, Cyclic
(pharmacology)
- Signal Transduction
(drug effects)
- Thapsigargin
(pharmacology)
|